These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 31154482)

  • 21. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
    van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
    Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
    Chidambaram V; Brierley JD; Cummings B; Bhayana R; Menezes RJ; Kennedy ED; Kirsch R; Jhaveri KS
    Abdom Radiol (NY); 2017 May; 42(5):1310-1318. PubMed ID: 28004138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy.
    Tan Z; Cheng L; Xie L; Zhang L; Lin Z; Han P; Li X
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):327-336. PubMed ID: 36271652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
    Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
    World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
    Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S
    Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
    Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
    Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.
    Bakke KM; Hole KH; Dueland S; Grøholt KK; Flatmark K; Ree AH; Seierstad T; Redalen KR
    Acta Oncol; 2017 Jun; 56(6):813-818. PubMed ID: 28464745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration.
    Fornell-Perez R; Perez-Alonso E; Porcel-de-Peralta G; Duran-Castellon A; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Orihuela-de-la-Cal ME; Loro-Ferrer JF
    Abdom Radiol (NY); 2019 Nov; 44(11):3674-3682. PubMed ID: 31332499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI.
    Bostel T; Dreher C; Wollschläger D; Mayer A; König F; Bickelhaupt S; Schlemmer HP; Huber PE; Sterzing F; Bäumer P; Debus J; Nicolay NH
    Radiat Oncol; 2020 Jul; 15(1):171. PubMed ID: 32653003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.
    Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
    Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry.
    Palmisano A; Di Chiara A; Esposito A; Rancoita PMV; Fiorino C; Passoni P; Albarello L; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2020 Oct; 75(10):798.e1-798.e11. PubMed ID: 32712007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response.
    Cho SH; Kim GC; Jang YJ; Ryeom H; Kim HJ; Shin KM; Park JS; Choi GS; Kim SH
    Acta Radiol; 2015 Sep; 56(9):1042-50. PubMed ID: 25270374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.